These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2765866)

  • 1. Effect of exogenous L-dopa on behavior in the rat: an in vivo voltammetric study.
    Nakazato T; Akiyama A
    Brain Res; 1989 Jun; 490(2):332-8. PubMed ID: 2765866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry.
    Hefti F; Melamed E
    Brain Res; 1981 Nov; 225(2):333-46. PubMed ID: 7306794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo voltammetric study of 6-hydroxydopamine-induced neuronal degradation.
    Nakazato T; Akiyama A
    J Neurochem; 1988 Oct; 51(4):1007-13. PubMed ID: 3138384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
    Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of L-dopa-induced circling in rats with nigral lesions by blockade of central dopa-decarboxylase: implications for mechanism of action of L-dopa in parkinsonism.
    Melamed E; Hefti F; Bitton V; Globus M
    Neurology; 1984 Dec; 34(12):1566-70. PubMed ID: 6504328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
    Jackson D; Abercrombie ED; Zigmond MJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antagonism of the behavioral responses to L-3-,4-dihydroxyphenylalanine by L-3-,4-dihydroxyphenylalanine cyclohexyl ester in conscious rats.
    Matsushita N; Misu Y; Goshima Y
    Eur J Pharmacol; 2009 Mar; 605(1-3):109-13. PubMed ID: 19168057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of subchronic treatment with selegiline on L-DOPA-induced increase in extracellular dopamine level in rat striatum.
    Adachi K; Miwa H; Kusumoto H; Shimazu S; Kondo T
    J Pharmacol Sci; 2006 Aug; 101(4):286-92. PubMed ID: 16891770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.
    Abercrombie ED; Bonatz AE; Zigmond MJ
    Brain Res; 1990 Aug; 525(1):36-44. PubMed ID: 2123121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of dopamine and its metabolites in the intracellular and extracellular compartments of the rat striatum after peripheral administration of L-[11C]dopa.
    Miwa S; Gillberg PG; Bjurling P; Yumoto N; Odano I; Watanabe Y; Långström B
    Brain Res; 1992 Apr; 578(1-2):122-8. PubMed ID: 1511268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic L-DOPA-pretreatment of rats: an electrophysiological and biochemical study in the basal ganglia.
    Jackson DM; Walters JR; Miller LP
    Brain Res; 1982 Nov; 250(2):271-82. PubMed ID: 6129029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of L-dopa on in vitro dopamine release from striatum.
    Snyder GL; Zigmond MJ
    Brain Res; 1990 Feb; 508(2):181-7. PubMed ID: 2106362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-evaluation of the L-dopa loading effect on dopamine metabolism in rat striatum.
    el Gemayel G; Trouvin JH; Prioux-Guyonneau M; Jacquot C; Cohen Y
    J Pharm Pharmacol; 1986 Feb; 38(2):134-6. PubMed ID: 2870159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats.
    Buck K; Ferger B
    Neurobiol Dis; 2008 Feb; 29(2):210-20. PubMed ID: 17920284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
    Xu K; Dluzen DE
    J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined administration of direct dopamine receptor agonists and L-dopa does not interfere with utilization of exogenous L-dopa in rat corpus striatum.
    Globus M; Melamed E
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):211-5. PubMed ID: 6310691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decarboxylation of exogenous L-3,4-dihydroxyphenylalanine in rat striatum as studied by in vivo voltammetry.
    Nakazato T; Akiyama A
    J Neurochem; 1992 Jan; 58(1):121-7. PubMed ID: 1727424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.